Skip to content
DealForma Logo White 250x42 1
  • Features
  • Pricing
  • Blog
    • DealForma Research
    • Media Coverage
  • Sign in
  • Features
  • Pricing
  • Blog
    • DealForma Research
    • Media Coverage
  • Sign in
  • Sign In
  • Schedule a demo

DealForma Research

Recent Articles

Neurology R&D Partnerships, M&A and Venture Funding by Tech - Q1 2025 Review

Neurology R&D Partnerships, M&A and Venture Funding by Tech – Q1 2025 Review

  • June 30, 2025
Neurology R&D Partnerships, M&A and Venture Funding

Neurology R&D Partnerships, M&A and Venture Funding – Q1 2025 Review

  • June 24, 2025
Cancer R&D Partnerships, M&A and Venture Funding by Tech - Q1 2025 Review

Cancer R&D Partnerships, M&A and Venture Funding by Tech – Q1 2025 Review

  • June 13, 2025
Cancer R&D Partnerships, M&A and Venture Funding Activity by TA - Q1 2025

Cancer R&D Partnerships, M&A and Venture Funding Activity by TA – Q1 2025

  • June 10, 2025
MedTech, Device, Digital Health, and Wearables M&A and Ventures – Q1 2025

MedTech, Device, Digital Health, and Wearables M&A and Ventures – Q1 2025

  • June 4, 2025
Biopharma Therapeutics and Platforms IPO Activity - Q1 2025 Review

Biopharma Therapeutics and Platforms IPO Activity – Q1 2025 Review

  • May 22, 2025
Biopharma Therapeutics and Platforms Venture Funding - Q1 2025 Review

Biopharma Therapeutics and Platforms Venture Funding – Q1 2025 Review

  • May 15, 2025
A117 - Biopharma Therapeutics and Platforms M&A - Q1 2025 Review

Biopharma Therapeutics and Platforms M&A Q1 2025

  • May 8, 2025
Biopharma Therapeutics and Platforms R&D Partnerships - Q1 2025 Review

Biopharma Therapeutics and Platforms R&D Partnerships Q1 2025

  • May 8, 2025
Gene Therapy R&D Partnerships, M&A and Ventures in 2024

Gene Therapy R&D Partnerships, M&A and Ventures in 2024

  • May 8, 2025
Autoimmune R&D Partnerships, M&A, Ventures, and IPOs in 2024

Autoimmune R&D Partnerships, M&A, Ventures, and IPOs in 2024

  • April 20, 2025
Global Healthcare and Life Sciences - Q1 2025 Review

Global Healthcare and Life Sciences – Q1 2025 Review

  • April 14, 2025
Neurologic R&D Partnerships, M&A, Ventures, and IPOs in 2024

Neurologic R&D Partnerships, M&A, Ventures, and IPOs in 2024

  • April 14, 2025
Previous Page1 Page2 Page3 Page4 Page5 Next

All of this by stage, disease indication, modality, target…

Schedule your demo
+ 0 k
Licensing Deals
+ 0 k
M&A
+ 0 k
Other Deals
+ 0 k
Funding Rounds
+ 0 k
Company Profiles
+ 0 k
Drug Sales Figures
DealForma Logo

DealForma is the biopharma deal database providing you comprehensive information and dedicated analyst support to help you be more confident using quality data in your business development research.

Linkedin X Social Media White Icon

Database

  • Features
  • Pricing
  • Features
  • Pricing

Company

  • About Us
  • Analysis / Blog
  • Case Studies
  • Contact Us
  • About Us
  • Analysis / Blog
  • Case Studies
  • Contact Us

Comparisons

  • Alternative to Evaluate Pharma
  • Alternative to BioSciDB
  • Alternative to Clarivate Cortellis
  • Alternative to BioCentury BCIQ
  • Alternative to PitchBook
  • Other Database Alternatives
  • Alternative to Evaluate Pharma
  • Alternative to BioSciDB
  • Alternative to Clarivate Cortellis
  • Alternative to BioCentury BCIQ
  • Alternative to PitchBook
  • Other Database Alternatives
  • Made in San Mateo, CA and around the world
  • support@dealforma.com
  • (650) 353-9363

Website Design by Once Interactive

  • Terms
  • Privacy
  • Copyright © 2025 DealForma
  • Features
  • Pricing
  • Blog
    • DealForma Research
    • Media Coverage
  • Sign in
Logo